11.4%
Revenue Growth
MCK achieved an 11.4% increase in revenue, driven by strong demand across its product lines.
来源: Source: 10-Q Income Statement, p.1
中文版正在生成中，先为你展示英文版分析。
AI核心结论
MCK reported strong financial performance in Q3 FY2026, with significant increases in revenue, operating income, and net income, despite ongoing cost pressures.
营业收入
$106.16B
同比 ++11.40%
每股收益（基本）
$9.63
同比 ++37.97%
毛利率
3.5%
同比 ++0.03%
营业利润
$1.62B
同比 ++32.27%
提交于 · 解读更新于 · 来源: SEC EDGAR 10-Q 原文
Mckesson (MCK) Q3 FY2026 营收 $106.16B，同比增长 11.4%。 净利润 $1.19B，同比增长 34.9%，稀释每股收益 $9.59。 毛利率 3.5%。
MCK achieved an 11.4% increase in revenue, driven by strong demand across its product lines.
来源: Source: 10-Q Income Statement, p.1
Operating income rose by 32.3%, reflecting improved operational efficiencies and cost management.
来源: Source: 10-Q Income Statement, p.1
Operating cash flow turned positive at $2.73B, indicating enhanced cash generation capabilities.
来源: Source: 10-Q Cash Flow, p.1
MCK's long-term debt increased by 17.4% to $6.56B, which could pressure future cash flows if interest rates rise.
来源: Source: 10-Q Balance Sheet, p.1
The company continues to have negative stockholders' equity, though it improved by 57.9% YoY, which may affect its financial flexibility.
来源: Source: 10-Q Balance Sheet, p.1
With a current ratio of 0.88, MCK may face liquidity challenges in meeting short-term obligations.
来源: Source: 10-Q Key Ratios, p.1
Q3 FY2026 实际 EPS $9.34，分析师一致预期 $9.31，超预期 +0.3%。
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营业收入 | $106.16B | $95.29B | +11.40% |
营业成本 | $102.47B | $92.01B | +11.37% |
毛利润 | $3.69B | $3.28B | +12.21% |
营业利润 | $1.62B | $1.22B | +32.27% |
净利润 | $1.19B | $879M | +34.93% |
每股收益（基本） | $9.63 | $6.98 | +37.97% |
每股收益（稀释） | $9.59 | $6.95 | +37.99% |
销售及管理费用 | $2.03B | $2.03B | +0.10% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
总资产 | $84.19B | $71.08B | +18.44% |
流动资产 | $59.7B | $51.74B | +15.38% |
流动负债 | $68.13B | $58.56B | +16.34% |
股东权益 | $-1.3B | $-3.08B | +57.91% |
现金及等价物 | $2.96B | $1.13B | +161.63% |
长期债务 | $6.56B | $5.59B | +17.36% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
经营活动现金流YTD | $2.73B | $-1.66B | +264.40% |
投资活动现金流YTD | $-3.86B | $-509M | -657.76% |
筹资活动现金流YTD | $-1.81B | $-1.11B | -63.15% |
股票回购YTD | $2.08B | $2.85B | -26.95% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
毛利率 | 3.5% | 3.4% | +0.03% |
营业利润率 | 1.5% | 1.3% | +0.24% |
净利率 | 1.1% | — | — |
净资产收益率 | -91.4% | — | — |
总资产收益率 | 1.4% | — | — |
流动比率 | $0.876 | — | — |
Health Care Distributors 行业其他公司
MCK reported a 38.0% increase in EPS to $9.63, indicating strong earnings performance, but specific estimates are not provided.
Key takeaways include an 11.4% revenue increase, a 34.9% rise in net income, and improved operating cash flow, despite liquidity challenges.
MCK's revenue grew by 11.4% YoY to $106.16B, driven by strong demand across its product lines.
Risks include high debt levels, negative equity, and a low current ratio, which could impact financial flexibility.
MCK shows strong revenue and income growth but faces challenges with liquidity and debt levels, as indicated by a current ratio of 0.88.